EcoDrugPlus

Ensembl ID : ENSUPAG00010009197
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSUPAG00010009364
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSUPAG00010008175
Gene Symbol: -
Cross references: -
115 Possible Orthologues:

Ensembl ID : ENSUPAG00010002831
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSUPAG00010006804
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSUPAG00010005289
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSUPAG00010001844
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSUPAG00010023858
Gene Symbol: -
Cross references: -
96 Possible Orthologues:

Ensembl ID : ENSUPAG00010020817
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSUPAG00010020812
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSUPAG00010004446
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSUPAG00010011969
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).